{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:05:33Z","timestamp":1791993933854,"version":"4.4.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40620-016-0271-z","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T04:37:11Z","timestamp":1454474231000},"page":"791-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Podocyturia is significantly elevated in untreated vs treated Fabry adult patients"],"prefix":"10.1093","volume":"29","author":[{"given":"Hern\u00e1n","family":"Trimarchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Canzonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Schiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Politei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00edbal","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Paulero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Rengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ar\u00e1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Forrester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Pomeranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Iriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Muryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Zotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,2,3]]},"reference":[{"key":"271_CR1","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou Y, Eng CM (2001) \u03b1-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3733\u20133774"},{"key":"271_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C Tondel","year":"2013","unstructured":"Tondel C, Bostad L, Larsen KK et al (2013) Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol 24:137\u2013148","journal-title":"J Am Soc Nephrol"},{"key":"271_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00041552-200503000-00002","volume":"14","author":"DJ Warnock","year":"2005","unstructured":"Warnock DJ (2005) Fabry disease: diagnosis and management, with emphasis on the renal manifestations. Curr Opin Nephrol Hyperten 14:87\u201395","journal-title":"Curr Opin Nephrol Hyperten"},{"key":"271_CR4","unstructured":"Trimarchi H, Forrester M, Lombi F et al (2014) Amiloride as an alternate adjuvant antiproteinuric agent in Fabry disease. The potential roles of plasmin and uPAR. Case Reports in Nephrology 1\u20136: ID 854521"},{"key":"271_CR5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz A, Oliveira JP, Waldek S et al (2008) Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transplant 23:1600\u20131607","journal-title":"Nephrol Dial Transplant"},{"key":"271_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.2010.484","volume":"79","author":"B Najafian","year":"2011","unstructured":"Najafian B, Svarstad E, Bostad L et al (2011) Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int 79:663\u2013670","journal-title":"Kidney Int"},{"key":"271_CR7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG et al (2002) Natural history of Fabry renal disease: influence of \u03b1-galactosidase A activity and genetic mutations on clinical course. Medicine 81:122\u2013138","journal-title":"Medicine"},{"key":"271_CR8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/11.supp7.4","volume":"11","author":"D Tsakiris","year":"1996","unstructured":"Tsakiris D, Simpson HK, Jones EH et al (1996) Report on management of renal failure in Europe-XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 11:4\u201320","journal-title":"Nephrol Dial Transplant"},{"key":"271_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","volume":"61","author":"R Thadhani","year":"2002","unstructured":"Thadhani R, Wolf M, West ML et al (2002) Patients with Fabry disease on dialysis in the United States. Kidney Int 61:249\u2013255","journal-title":"Kidney Int"},{"key":"271_CR10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T et al (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype. Kidney Int 64:801\u2013807","journal-title":"Kidney Int"},{"key":"271_CR11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D et al (2004) Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 15:1323\u20131329","journal-title":"J Am Soc Nephrol"},{"key":"271_CR12","doi-asserted-by":"crossref","unstructured":"Trimarchi H, Canzonieri R, Muryan A, et al (2015) Copious podocyturia without proteinuria and with normal renal function in a young adult with Fabry disease. Case Reports in Nephrology 257628","DOI":"10.1155\/2015\/257628"},{"key":"271_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5414\/CN108317","volume":"3","author":"N Takahashi","year":"2015","unstructured":"Takahashi N, Yokoi S, Kasuno K (2015) A heterogeneous female with Fabry disease due to a nivel alpha-galactosidase A mutation exhibits a ubnique synaptopodin distributin in vacuolated podocytes. Clin Nephrol 3:301\u2013308","journal-title":"Clin Nephrol"},{"key":"271_CR14","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1172\/JCI200523371","volume":"115","author":"K Anasuma","year":"2005","unstructured":"Anasuma K, Kim K, Oh J et al (2005) Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 115:1188\u20131198","journal-title":"J Clin Invest"},{"key":"271_CR15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1177\/002215540305101203","volume":"51","author":"K Ichimura","year":"2003","unstructured":"Ichimura K, Kurihara H, Sakai T (2003) Actin filament organization of foot process in rat podocytes. J Histochem Cytochem 51:1589\u20131600","journal-title":"J Histochem Cytochem"},{"key":"271_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","volume":"74","author":"A Greka","year":"2012","unstructured":"Greka A, Mundel P (2012) Cell biology and pathology of podocytes. Annu Rev Physiol 74:299\u2013323","journal-title":"Annu Rev Physiol"},{"key":"271_CR17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S et al (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931\u2013938","journal-title":"Nat Med"},{"key":"271_CR18","doi-asserted-by":"crossref","unstructured":"Smoyer WE, Mundel P, Gupta E et al (1997) Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome. Am J Physiol 273 Renal Physiol 42:F150\u2013F157","DOI":"10.1152\/ajprenal.1997.273.1.F150"},{"key":"271_CR19","doi-asserted-by":"crossref","first-page":"F40","DOI":"10.1152\/ajprenal.00404.2002","volume":"285","author":"SU Vogelmann","year":"2003","unstructured":"Vogelmann SU, Nelson WJ, Myers BD et al (2003) Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 285:F40\u2013F48","journal-title":"Am J Physiol Renal Physiol"},{"key":"271_CR20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneph.2014.87","volume":"10","author":"A Fornoni","year":"2014","unstructured":"Fornoni A, Merscher S, Kopp JB (2014) Lipid biology of podocyte-new perspectives offer new opportunities. Nat Rev Nephrol 10:379\u2013388","journal-title":"Nat Rev Nephrol"},{"key":"271_CR21","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","volume":"16","author":"BL Wharram","year":"2005","unstructured":"Wharram BL, Goyal M, Wiggins JE et al (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16:2941\u20132952","journal-title":"J Am Soc Nephrol"},{"key":"271_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1515\/jtim-2015-0003","volume":"3","author":"H Trimarchi","year":"2015","unstructured":"Trimarchi H (2015) Podocyturia. What is in a name? J Translat Internal Med 3:51\u201356","journal-title":"J Translat Internal Med"},{"key":"271_CR23","doi-asserted-by":"publisher","unstructured":"Jim B, Jean-Louis P, Qipo A et al (2012) Podocyturia as a diagnostic marker of preeclampsia amongst high-risk pregnant patients. J of Pregnancy ID 984630. doi: 10.1155\/2012\/984630","DOI":"10.1155\/2012\/984630"},{"key":"271_CR24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5935\/0101-2800.20130043","volume":"35","author":"S Rodrigues Pereira","year":"2013","unstructured":"Rodrigues Pereira S, Castro Teixeira V, Nishida SK (2013) Detection of podocyturia in patients with lupus nephritis. J Brasil Nefrol 35:252\u2013258","journal-title":"J Brasil Nefrol"},{"key":"271_CR25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1053\/j.ajkd.2014.08.016","volume":"64","author":"S Maestroni","year":"2014","unstructured":"Maestroni S, Maestroni A, Dell\u2019Antonio G et al (2014) Viable podocyturia in healthy individuals: implications for podocytopathies. Am J Kidney Dis 64:1003\u20131005","journal-title":"Am J Kidney Dis"},{"key":"271_CR26","doi-asserted-by":"crossref","first-page":"e112188","DOI":"10.1371\/journal.pone.0112188","volume":"9","author":"M Mauer","year":"2014","unstructured":"Mauer M, Glynn E, Svarstad E et al (2014) Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease. Plos One 9:e112188","journal-title":"Plos One"},{"key":"271_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","volume":"52","author":"DP Germain","year":"2015","unstructured":"Germain DP, Charrow J, Desnick RJ et al (2015) Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J Med Genet 52:353\u2013358","journal-title":"J Med Genet"},{"key":"271_CR28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40620-015-0193-1","volume":"6","author":"M Gaggl","year":"2015","unstructured":"Gaggl M, Hofer M, Weidner S et al (2015) Interfering parameters in the determination of urinary globotriasocylceramide (Gb3) in patients with chronic kidney disease. J Nephrol 6:679\u2013689","journal-title":"J Nephrol"},{"key":"271_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0009-8981(98)00169-7","volume":"279","author":"K Utsumi","year":"1999","unstructured":"Utsumi K, Itoh K, Kase R et al (1999) Urinary excretion of the vitronectin receptor (integrin \u03b1 V \u03b2 3) in patients with Fabry disease. Clin Chimica Acta 279:55\u201368","journal-title":"Clin Chimica Acta"},{"key":"271_CR30","unstructured":"Trimarchi H (2015) Plasmin, urokinase plasminogen activator receptor and amiloride in the nephrotic syndrome. In: Nephrotic syndrome. Etiology, pathogenesis and pathology. Mubarak M (ed) Nova Biomedical, New York"},{"key":"271_CR31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0037-1616208","volume":"86","author":"HA Chapman","year":"2001","unstructured":"Chapman HA, Wei Y (2001) Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb Haemost 86:124\u2013129","journal-title":"Thromb Haemost"},{"key":"271_CR32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei C, M\u00f6ller CC, Altintas MM et al (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55\u201363","journal-title":"Nat Med"},{"key":"271_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s001250050637","volume":"40","author":"M Regoli","year":"1997","unstructured":"Regoli M, Bendayan M (1997) Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus. Diabetologia 40:15\u201322","journal-title":"Diabetologia"},{"key":"271_CR34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrneph.2012.291","volume":"9","author":"N Sachs","year":"2013","unstructured":"Sachs N, Sonnenberg A (2013) Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol 9:200\u2013210","journal-title":"Nat Rev Nephrol"},{"key":"271_CR35","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/ndt\/gfq306","volume":"26","author":"MD Sanchez-Ni\u00f1o","year":"2011","unstructured":"Sanchez-Ni\u00f1o MD, Sanz AB, Carrasco S et al (2011) Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. Nephrol Dial Transplant 26:1797\u20131802","journal-title":"Nephrol Dial Transplant"},{"key":"271_CR36","doi-asserted-by":"crossref","first-page":"e63506","DOI":"10.1371\/journal.pone.0063506","volume":"8","author":"MC Liebau","year":"2013","unstructured":"Liebau MC, Braun F, H\u00f6pker K et al (2013) Dysregulated autophagy contributes to podocyte damage in Fabry\u2019s disease. PLoS One 8:e63506","journal-title":"PLoS One"},{"issue":"20","key":"271_CR37","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/hmg\/ddv291","volume":"24","author":"MD Sanchez-Ni\u00f1o","year":"2015","unstructured":"Sanchez-Ni\u00f1o MD, Carpio D, Sanz AB, Ruiz-Ortega M, Mezzano S, Ortiz A (2015) Lyso-GB3 activates Notch 1 in humaan podocytes. Hum Mol Genet 24(20):5720\u20135734","journal-title":"Hum Mol Genet"},{"key":"271_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3116-4","author":"J M\u00fcller-Deile","year":"2015","unstructured":"M\u00fcller-Deile J, Schiffer M (2015) Podocyte directed therapy of nephrotic syndrome-can we bring the inside out? Pediatr Nephrol. doi: 10.1007\/s00467-015-3116-4","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"271_CR39","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/39.8.1856454","volume":"39","author":"P Mundel","year":"1991","unstructured":"Mundel P, Gilbert P, Kriz W (1991) Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem 39(8):1047\u20131056","journal-title":"J Histochem Cytochem"},{"key":"271_CR40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/ndt\/15.9.1379","volume":"15","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ushiyama C, Suzuki S et al (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15:1379\u20131383","journal-title":"Nephrol Dial Transplant"}],"updated-by":[{"DOI":"10.1007\/s40620-016-0293-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000}}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-016-0271-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0271-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:53Z","timestamp":1777564613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/6\/791\/8371233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,3]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1007\/s40620-016-0271-z","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,3]]}}}